{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:11:26Z","timestamp":1790856686372,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T00:00:00Z","timestamp":1628640000000},"content-version":"am","delay-in-days":314,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.lpm.2020.104039","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T12:37:44Z","timestamp":1594125464000},"page":"104039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Lung involvement in ANCA-associated vasculitis"],"prefix":"10.1016","volume":"49","author":[{"given":"Goethe","family":"Sacoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Boukhlal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Specks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis Felipe","family":"Flores-Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divi","family":"Cornec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lpm.2020.104039_bib0420","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0425","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/1756-185X.13071","article-title":"Clinical features and long-term outcomes of 105 granulomatosis with polyangiitis patients: A single center experience from north India","volume":"21","author":"Sharma","year":"2018","journal-title":"Int J Rheum Dis"},{"issue":"8","key":"10.1016\/j.lpm.2020.104039_bib0430","doi-asserted-by":"crossref","first-page":"e6083","DOI":"10.1097\/MD.0000000000006083","article-title":"Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: Impact of the vasculitis type. ANCA specificity, and treatment on mortality and morbidity","volume":"96","author":"Solans-Laqu\u00e9","year":"2017","journal-title":"Medicine"},{"issue":"9","key":"10.1016\/j.lpm.2020.104039_bib0435","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3899\/jrheum.131426","article-title":"Predictors for mortality in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis: a study of 398 chinese patients","volume":"41","author":"Lai","year":"2014","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.lpm.2020.104039_bib0440","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","article-title":"Long-term patient survival in ANCA-associated vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.lpm.2020.104039_bib0445","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/rheumatology\/key285","article-title":"Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides","volume":"58","author":"Garen","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.lpm.2020.104039_bib0450","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jcrc.2018.08.037","article-title":"Patients with small-vessel vasculitides have the highest mortality among systemic autoimmune diseases patients treated in intensive care unit: a retrospective study with 5-year follow-up","volume":"48","author":"W\u0142udarczyk","year":"2018","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"04","key":"10.1016\/j.lpm.2020.104039_bib0460","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1055\/s-0038-1660874","article-title":"Granulomatosis with Polyangiitis (Wegener's Granulomatosis): evolving concepts in treatment","volume":"39","author":"Lynch","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.lpm.2020.104039_bib0465","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0002-9440(10)61118-2","article-title":"Peripheral Blood and Granuloma CD4+CD28\u2212T Cells Are a Major Source of Interferon-\u03b3 and Tumor Necrosis Factor-\u03b1 in Wegener's Granulomatosis","volume":"160","author":"Komocsi","year":"2002","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"10.1016\/j.lpm.2020.104039_bib0470","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.rdc.2010.05.008","article-title":"Clinical manifestations and treatment of Wegener's granulomatosis","volume":"36","author":"Holle","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"issue":"2","key":"10.1016\/j.lpm.2020.104039_bib0475","first-page":"176","article-title":"[Clinical Characteristics of antineutrophil cytoplasmic antibody-associated vasculitis in a respiratory diseases referral center in Mexico (1982\u20132010)]","volume":"151","author":"Flores-Su\u00e1rez","year":"2015","journal-title":"Gac Med Mex"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0480","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/resp.12738","article-title":"Biopsy-proven pulmonary capillaritis: a retrospective study of aetiologies including an in-depth look at isolated pulmonary capillaritis: in-depth look at pulmonary capillaritis","volume":"21","author":"Thompson","year":"2016","journal-title":"Respirology"},{"issue":"36","key":"10.1016\/j.lpm.2020.104039_bib0485","first-page":"195","article-title":"Wegener's granulomatosis in the 1990s--a pulmonary pathologist's perspective","author":"Colby","year":"1993","journal-title":"Monogr Pathol"},{"issue":"2","key":"10.1016\/j.lpm.2020.104039_bib0490","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1164\/ajrccm.151.2.7842215","article-title":"Tracheobronchial involvement in Wegener's granulomatosis","volume":"151","author":"Daum","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"10.1016\/j.lpm.2020.104039_bib0495","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"De Groot","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.lpm.2020.104039_bib0500","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/ard.2011.153601","article-title":"Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations","volume":"71","author":"Holle","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.lpm.2020.104039_bib0505","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.lpm.2020.104039_bib0510","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.autrev.2008.07.010","article-title":"Use of glucocorticoids and risk of infections","volume":"8","author":"Cutolo","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.lpm.2020.104039_bib0515","first-page":"129","article-title":"Rate of infections in severe necrotising vasculitis patients treated with cyclophosphamide induction therapy: a meta-analysis","volume":"36 Suppl 111","author":"Jung","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0520","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1056\/NEJM199607043350103","article-title":"Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group","volume":"335","author":"Stegeman","year":"1996","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.lpm.2020.104039_bib0525","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1378\/chest.11-1050","article-title":"Reversed Halo Sign","volume":"141","author":"Marchiori","year":"2012","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0530","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.rdc.2007.09.004","article-title":"Airway involvement in Wegener's Granulomatosis","volume":"33","author":"Polychronopoulos","year":"2007","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0535","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/thx.45.4.300","article-title":"Subglottic stenosis in Wegener's granulomatosis: development during cyclophosphamide treatment with response to carbon dioxide laser therapy","volume":"45","author":"Strange","year":"1990","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.lpm.2020.104039_bib0540","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1378\/chest.114.3.796","article-title":"Long-term results of fiberoptic bronchoscopic balloon dilation in the management of benign tracheobronchial stenosis","volume":"114","author":"Sheski","year":"1998","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lpm.2020.104039_bib0545","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0022-5223(96)70371-9","article-title":"Subglottic stenosis complicating Wegener's granulomatosis: surgical repair as a viable treatment option","volume":"111","author":"Herridge","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"8","key":"10.1016\/j.lpm.2020.104039_bib0550","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1097\/00005537-200308000-00008","article-title":"Subglottic stenosis associated with Wegener's granulomatosis","volume":"113","author":"Gluth","year":"2003","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0555","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1055\/s-0038-1673387","article-title":"Microscopic polyangiitis: new insights into pathogenesis, clinical features and therapy","volume":"39","author":"Karras","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.lpm.2020.104039_bib0560","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1136\/annrheumdis-2015-208073","article-title":"Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type","volume":"75","author":"Unizony","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0565","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1055\/s-0038-1669454","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"39","author":"Nguyen","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.lpm.2020.104039_bib0570","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.39562","article-title":"Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes","volume":"68","author":"Cartin-Ceba","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.lpm.2020.104039_bib0575","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1183\/09031936.00075309","article-title":"Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality","volume":"35","author":"de Prost","year":"2010","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0580","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9343(03)00359-0","article-title":"Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists","volume":"115","author":"Keogh","year":"2003","journal-title":"Am J Med"},{"issue":"9","key":"10.1016\/j.lpm.2020.104039_bib0585","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","article-title":"Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome","volume":"52","author":"Sinico","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0590","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/art.37721","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort","volume":"65","author":"Comarmond","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.lpm.2020.104039_bib0595","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1378\/chest.08-2084","article-title":"Diffuse alveolar hemorrhage","volume":"137","author":"Lara","year":"2010","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0600","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-0038-1669412","article-title":"Diffuse alveolar hemorrhage and pulmonary vasculitides: histopathologic findings","volume":"39","author":"Scapa","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.lpm.2020.104039_bib0605","doi-asserted-by":"crossref","first-page":"223","DOI":"10.5858\/arpa.2016-0098-RA","article-title":"Pathology of antineutrophil cytoplasmic antibody-associated pulmonary and renal disease","volume":"141","author":"Smith","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.lpm.2020.104039_bib0610","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1148\/rg.242025714","article-title":"Nontraumatic emergent abdominal vascular conditions: advantages of multi-detector row CT and three-dimensional imaging","volume":"24","author":"Frauenfelder","year":"2004","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0615","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1378\/chest.121.1.242","article-title":"CT virtual bronchoscopy of the central airways in patients with Wegener's granulomatosis","volume":"121","author":"Summers","year":"2002","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.lpm.2020.104039_bib0620","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1183\/09031936.97.10122738","article-title":"Efficacy of transbronchial biopsy in pulmonary vaculitides","volume":"10","author":"Schnabel","year":"1997","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0625","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/ajrccm.151.1.7812547","article-title":"Alveolar hemorrhage. Diagnostic criteria and results in 194 immunocompromised hosts","volume":"151","author":"De Lassence","year":"1995","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.lpm.2020.104039_bib0630","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1378\/chest.120.6.2013","article-title":"Time course of hemosiderin production by alveolar macrophages in a murine model","volume":"120","author":"Epstein","year":"2001","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.lpm.2020.104039_bib0635","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/00000478-199012000-00003","article-title":"A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation","volume":"14","author":"Travis","year":"1990","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.lpm.2020.104039_bib0640","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lpm.2020.104039_bib0645","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.lpm.2020.104039_bib0650","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1213277","article-title":"Efficacy of remission-induction regimens for ANCA-associated vasculitis","volume":"369","author":"Specks","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2020.104039_bib0655","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.rmed.2017.06.003","article-title":"Immune diffuse alveolar hemorrhage: cinical presentation and outcome","volume":"129","author":"Quadrelli","year":"2017","journal-title":"Respir Med"},{"issue":"10","key":"10.1016\/j.lpm.2020.104039_bib0660","first-page":"2017","article-title":"Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations","volume":"35","author":"Seo","year":"2008","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.lpm.2020.104039_bib0665","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1053\/j.ajkd.2003.08.015","article-title":"Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis","volume":"42","author":"Klemmer","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0670","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/ajkd.2002.29876","article-title":"Pulmonary renal syndrome: a 4-year, single-center experience","volume":"39","author":"Gallagher","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0675","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1378\/chest.126.1.305","article-title":"Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage","volume":"126","author":"Ahmed","year":"2004","journal-title":"Chest"},{"issue":"Suppl 1","key":"10.1016\/j.lpm.2020.104039_bib0680","first-page":"51","article-title":"Interstitial Lung Disease with ANCA-associated Vasculitis","volume":"9","author":"Katsumata","year":"2015","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"issue":"7","key":"10.1016\/j.lpm.2020.104039_bib0685","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.autrev.2017.05.008","article-title":"Interstital lung disease in ANCA vasculitis","volume":"16","author":"Alba","year":"2017","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0690","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1055\/s-0038-1669914","volume":"39","author":"Borie","year":"2018","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0695","doi-asserted-by":"crossref","first-page":"e000058","DOI":"10.1136\/bmjresp-2014-000058","article-title":"Antineutrophil cytoplasmic antibody-positive conversion and microscopic polyangiitis development in patients with idiopathic pulmonary fibrosis","volume":"2","author":"Kagiyama","year":"2015","journal-title":"BMJ Open Respir Res"},{"issue":"6","key":"10.1016\/j.lpm.2020.104039_bib0700","doi-asserted-by":"crossref","first-page":"e0199659","DOI":"10.1371\/journal.pone.0199659","article-title":"Clinical significance of myeloperoxidase-anti-neutrophil cytoplasmic antibody in idiopathic interstitial pneumonias","volume":"13","author":"Hozumi","year":"2018","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.lpm.2020.104039_bib0705","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.39786","volume":"68","author":"Schirmer","year":"2016","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.lpm.2020.104039_bib0710","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9343(80)90009-1","article-title":"Functional correlates of lung involvement in Wegener's granulomatosis. Use of pulmonary function tests in staging and follow-up","volume":"69","author":"Rosenberg","year":"1980","journal-title":"Am J Med"},{"issue":"24","key":"10.1016\/j.lpm.2020.104039_bib0715","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MD.0000000000000217","article-title":"Pulmonary fibrosis in antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: a series of 49 patients and review of the literature","volume":"93","author":"Comarmond","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.lpm.2020.104039_bib0720","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1164\/rccm.201506-1063ST","article-title":"An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline","volume":"192","author":"Raghu","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.lpm.2020.104039_bib0725","doi-asserted-by":"crossref","first-page":"17074","DOI":"10.1038\/nrdp.2017.74","article-title":"Idiopathic pulmonary fibrosis","volume":"3","author":"Martinez","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"10.1016\/j.lpm.2020.104039_bib0730","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s10157-012-0733-0","article-title":"Limited pulmonary MPA, a new MPA entity? A rheumatologist's perspective","volume":"17","author":"Flores-Su\u00e1rez","year":"2013","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0735","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005792-199901000-00003","article-title":"Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients","volume":"78","author":"Guillevin","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.lpm.2020.104039_bib0740","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1183\/13993003.00097-2016","article-title":"Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"48","author":"Cottin","year":"2016","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0745","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1398-9995.2008.01854.x","article-title":"Persistent airflow obstruction in asthma of patients with Churg-Strauss syndrome and long-term follow-up","volume":"64","author":"Cottin","year":"2009","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0750","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s40674-017-0073-z","article-title":"Current and future treatment options for eosinophilic granulomatosis with polyangiitis","volume":"3","author":"Berti","year":"2017","journal-title":"Curr Treat Options in Rheum"},{"key":"10.1016\/j.lpm.2020.104039_bib0755","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.rmed.2018.07.017","article-title":"Severe\/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis","volume":"142","author":"Berti","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.lpm.2020.104039_bib0760","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.rmed.2018.05.003","article-title":"Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis","volume":"139","author":"Nakamoto","year":"2018","journal-title":"Respir Med"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0765","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005792-199601000-00003","article-title":"Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients","volume":"75","author":"Guillevin","year":"1996","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0770","doi-asserted-by":"crossref","first-page":"e000905","DOI":"10.1136\/rmdopen-2019-000905","article-title":"Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis","volume":"5","author":"Teixeira","year":"2019","journal-title":"RMD Open"},{"issue":"6","key":"10.1016\/j.lpm.2020.104039_bib0775","first-page":"1556","article-title":"Rituximab as induction therapy in eosinophilic granulomatosis with polyangiitis refractory to conventional immunosuppressive treatment: a 36-month follow-up analysis","volume":"5","author":"Thiel","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.lpm.2020.104039_bib0780","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/annrheumdis-2014-206095","article-title":"Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)","volume":"75","author":"Mohammad","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.lpm.2020.104039_bib0785","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1002\/art.34584","article-title":"Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center","volume":"64","author":"Cartin-Ceba","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"20","key":"10.1016\/j.lpm.2020.104039_bib0790","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler","year":"2017","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.lpm.2020.104039_bib0795","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.jaci.2010.03.028","article-title":"Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome","volume":"125","author":"Kim","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.lpm.2020.104039_bib0800","doi-asserted-by":"crossref","first-page":"341","DOI":"10.7326\/0003-4819-155-5-201109060-00026","article-title":"Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome","volume":"155","author":"Moosig","year":"2011","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.lpm.2020.104039_bib0805","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/art.20718","article-title":"Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"Keogh","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.lpm.2020.104039_bib0810","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1164\/rccm.200507-1144OC","article-title":"Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial","volume":"173","author":"Keogh","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.lpm.2020.104039_bib0815","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1093\/rheumatology\/kez217","article-title":"Subglottic stenosis and endobronchial disease in granulomatosis with polyangiitis","volume":"58","author":"Quinn","year":"2019","journal-title":"Rheumatology"},{"issue":"21","key":"10.1016\/j.lpm.2020.104039_bib0820","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1056\/NEJMoa1113354","article-title":"The idiopathic pulmonary fibrosis Clinical Research Network. Prednisone, azathioprine, and N -acetylcysteine for pulmonary fibrosis","volume":"366","author":"The Idiopathic Pulmonary Fibrosis Clinical Research Network","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2020.104039_bib0825","doi-asserted-by":"crossref","DOI":"10.1080\/1744666X.2019.1697678","article-title":"Eosinophilic granulomatosis with polyangiitis: the multifaceted spectrum of clinical manifestations at different stages of the disease","volume":"16","author":"Berti","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.lpm.2020.104039_bib0830","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.semarthrit.2018.05.005","article-title":"Frequency, treatment, evolution, and factors associated with the presence of tracheobronchial stenoses in granulomatosis with polyangiitis. Retrospective analysis of a case series from a single respiratory referral center","volume":"48","author":"Marroqu\u00edn-Fabi\u00e1n","year":"2019","journal-title":"Semin Arthritis Rheum"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498220300270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498220300270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:07:21Z","timestamp":1760105241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498220300270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0755498220300270"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2020.104039","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung involvement in ANCA-associated vasculitis","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2020.104039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104039"}}